Title:
beta 2-ADRENERGIC RECEPTOR AGONISTS
Document Type and Number:
WIPO Patent Application WO1999064035
Kind Code:
A9
Abstract:
Disclosed are multibinding compounds which are beta 2-adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.
Inventors:
GRIFFIN JOHN H (US)
MORAN EDMUND J (US)
CHOI SEOK-KI (US)
MORAN EDMUND J (US)
CHOI SEOK-KI (US)
Application Number:
PCT/US1999/011804
Publication Date:
July 06, 2000
Filing Date:
June 07, 1999
Export Citation:
Assignee:
ADVANCED MEDICINE INC (US)
GRIFFIN JOHN H (US)
MORAN EDMUND J (US)
CHOI SEOK KI (US)
GRIFFIN JOHN H (US)
MORAN EDMUND J (US)
CHOI SEOK KI (US)
International Classes:
A61K31/13; A61K31/136; A61K31/137; A61K31/155; A61K31/16; A61K31/18; A61K31/27; A61K31/40; A61K31/4015; G01N33/50; A61K31/403; A61K31/404; A61K31/41; A61K31/4164; A61K31/4178; A61K31/4184; A61K31/435; A61K31/437; A61K31/44; A61K31/4402; A61K31/4427; A61K31/4439; A61K31/445; A61K31/454; A61K31/4545; A61K31/47; A61K31/4706; A61K31/4709; A61K31/485; A61K31/495; A61K31/496; A61K31/498; A61K31/506; A61K31/517; A61K31/519; A61K31/55; A61K31/551; A61K31/5517; A61K31/662; A61K38/00; A61K45/00; A61K47/48; A61P9/02; A61P9/04; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/02; A61P13/08; A61P15/06; A61P17/04; A61P21/00; A61P25/00; A61P25/02; A61P25/04; A61P25/06; A61P25/08; A61P25/14; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P27/16; A61P43/00; C07B61/00; C07C211/00; C07C213/00; C07C215/00; C07C215/34; C07C215/60; C07C217/00; C07C217/08; C07C217/10; C07C217/48; C07C217/58; C07C217/90; C07C237/08; C07C271/12; C07C311/37; C07C323/44; C07C323/62; C07D207/06; C07D207/08; C07D207/26; C07D209/08; C07D211/14; C07D211/18; C07D211/42; C07D211/52; C07D211/56; C07D211/60; C07D211/72; C07D211/84; C07D213/30; C07D213/38; C07D213/56; C07D213/74; C07D213/75; C07D213/80; C07D215/22; C07D215/48; C07D221/26; C07D221/28; C07D223/04; C07D235/18; C07D235/30; C07D239/95; C07D241/44; C07D249/12; C07D257/04; C07D263/32; C07D263/34; C07D265/32; C07D277/24; C07D277/28; C07D277/34; C07D295/02; C07D295/06; C07D295/08; C07D295/18; C07D295/20; C07D401/04; C07D401/12; C07D401/14; C07D403/02; C07D403/14; C07D413/06; C07D413/14; C07D417/12; C07D471/04; C07D471/08; C07D487/04; C07D495/04; C07D519/00; C07K1/04; C07K2/00; C07K4/00; C07K7/14; C07K16/28; C40B20/00; G01N33/15; G01N33/53; G01N33/543; G01N33/566; G01N33/94; G01N37/00; (IPC1-7): A61K38/00; A61K39/00; A61K39/44; A61K39/395; A61K51/00; G01N33/53; G01N33/543; G01N33/566; C07C213/00
Download PDF:
Previous Patent: beta 2-ADRENERGIC RECEPTOR AGONISTS
Next Patent: NOVEL THERAPEUTIC AGENTS FOR MACROMOLECULAR STRUCTURES
Next Patent: NOVEL THERAPEUTIC AGENTS FOR MACROMOLECULAR STRUCTURES